Skip to main content
. Author manuscript; available in PMC: 2016 Nov 21.
Published in final edited form as: J Antibiot (Tokyo). 2016 May 18;70(1):65–72. doi: 10.1038/ja.2016.52

Table 1.

MIC (µg/ml) of ampicillin-tetramic acid hybrids against gram-positive bacteria.

Compound EF SPy SP BA BS MSSA MRSA
ampicillin 3.13 <0.2 <0.2 <0.2 <0.2 <0.2 50
piperacillin 3.13 <0.2 <0.2 0.39 0.39 <0.2 25
carbenicillin 3.13 <0.2 <0.2 <0.2 <0.2 <0.2 6.25
1903 25 0.39 0.39 3.13 1.56 0.78 25
1905 50 0.78 <0.2 3.13 3.13 0.78 50
1940 25 0.78 0.78 3.13 3.13 1.56 25
2742 25 1.56 1.56 6.25 3.13 1.56 100
2743 12.5 <0.2 <0.2 0.78 0.78 0.78 25
2744 12.5 0.78 0.39 6.25 3.13 1.56 25
2745 12.5 0.78 0.39 6.25 3.13 0.78 25
2746 25 0.39 0.39 1.56 3.13 1.56 50
2780 25 0.78 0.39 1.56 0.78 0.39 50
2781 25 0.39 <0.2 3.13 0.78 <0.2 25
2782 6.25 0.78 0.39 3.13 1.56 0.39 12.5
2833 12.5 0.78 <0.2 1.56 0.39 <0.2 25
2835 25 0.78 <0.2 3.13 <0.2 <0.2 25
2916 25 0.39 <0.2 1.56 1.56 <0.2 50
2917 25 0.39 <0.2 3.13 1.56 0.78 50
2918 25 1.56 0.39 6.25 3.13 0.78 50
2919 25 0.78 <0.2 3.13 1.56 0.78 50
3002 25 0.39 0.39 3.13 1.56 0.78 50

Key: EF= E. faecalis ATCC33186; SPy= S. pyogenes ATCC700294; SP= S. pneumoniae R6; BA= B. anthracis sterne; BS= B. subtilis ATCC23857; MSSA= S. aureus -ATCC29213; MRSA= S. aureus NRS 70.